摘要
目的:观察凯西莱联合血脂康治疗脂肪性肝炎的临床疗效。方法:选取69例脂肪性肝炎患者,随机分成两组。观察组38例,采用凯西莱联合血脂康治疗;对照组31例,采用血脂康治疗。疗程均为1个月。结果:观察组降酶降脂作用显著(P<0.01),总有效率达92.1％;对照组降酶作用不显著(P>0.05),但降脂作用显著(P<0.05),总有效率为61.3％。两组患者的总有效率比较,差异有显著性意义P<0.01)。结论:凯西莱联合血脂康是治疗脂肪性肝炎的有效方法之一。
Objctive: To observe the efficacy of Tiopronin combined with Xuezhikang in the treatment of steatohepatitis. Methods: 69 cases with steatohepatitis were randomly divided into two groups. 38 cases of observed group were given Tiopronin combined with Xuezhikang for one month; 31 cases of control group were given Xuezhikang only for one month. Results: At the end of treatment, the levels of serum ATS, ALT, TC and TG were significantly decreased in the observed group (P<0.01). And the levels of serum TC and TG were also significantly decreased in the control group (P< 0.05), but the levels of serum AST and ALT were not significantly reduced ( P > 0.05 ). The total therapeutic efficacy rate was higher in the observed group (92.1%) than in the control group (61.3%, P<0.01). Conclusion: It indicated that Tiopronin combined with Xuezhikang to treat steatohepatitis is more effective.
出处
《中西医结合肝病杂志》
CAS
2002年第6期339-340,共2页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
